Abstract: Novel 3,3-diphenylpropylamines of the formula and stereoisomers and physiologically acceptable acid addition salt thereof; wherein R1, R2, R3, R4, R5, and R6 are as defined herein; methods of use thereof; and pharmaceutical compositions thereof.

Abstract: Novel 3,3-diphenylpropylamines of the formula and stereoisomers and physiologically acceptable acid addition salt thereof; wherein R1, R2, R3, R4, R5, and R6 are as defined herein; methods of use thereof; and pharmaceutical compositions thereof.

Abstract: Novel 3,3-diphenylpropylamines of the formula and any stereoisomers thereof; wherein R1 represents —H or —CH3; R2 represents —CX3, —CR2-1X2, —CR2-1R2-2X, or —CR2-1R2-2H, wherein X represents halogen, and R2-1 and R2-2 independently represent —H or —(C1-C4 alkyl), optionally substituted with halogen; R3 and R4 independently represent —H, —OCH3, —OH, —CONH2, —SO2NH2, —F, —Cl, —Br, —I, —CF3, or —(C1-C4 alkyl), optionally substituted with one or two —OH, —(C1-C4 alkoxy), —COOH, or —CO—O—(C1-C3 alkyl); and R5 and R6 independently represent C1-C6 alkyl, optionally substituted with hydroxyl, wherein R5 and R6 together contain at least three carbon atoms, and wherein R5 and R6 may form a ring together with the amine nitrogen; provided that R2 comprises at least one halogen; or a physiologically acceptable acid addition salt thereof; the 3,3-diphenylpropylamines for use as medicaments, use of the 3,3-diphenylpropylamines for the manufacture of specific medicaments, and pharmaceutical compositions comprising the 3